Cargando…

Detectable antibodies against SARS-CoV-2 in newborns from mothers infected with COVID-19 at different gestational ages

Detalles Bibliográficos
Autores principales:	Mo, Huaheng, Wang, Ming, Wang, Mengmei, Han, Yi, Zhang, Yingying, Hu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997304/ https://www.ncbi.nlm.nih.gov/pubmed/33836982 http://dx.doi.org/10.1016/j.pedneo.2021.03.011

Ejemplares similares

Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19
por: Chen, Yi-Ching, et al.
Publicado: (2021)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
por: Sugiyama, Kazuo, et al.
Publicado: (2022)

Evidence of antibodies against SARS‐CoV‐2 in wild mustelids from Brittany (France)
por: Davoust, Bernard, et al.
Publicado: (2022)

A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein
por: Liang, Yuanhao, et al.
Publicado: (2021)

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
por: Hiroi, Satoshi, et al.
Publicado: (2023)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

Effect of Kangaroo Mother Care on Vital Physiological Parameters of The Low Birth Weight Newborn
por: Bera, Alpanamayi, et al.
Publicado: (2014)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2021)

Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2022)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Complications in neonates of mothers with gestational diabetes mellitus receiving insulin therapy versus dietary regimen
por: Fazel-Sarjoui, Zhaleh, et al.
Publicado: (2016)

Collaborated effort against SARS‐CoV‐2 outbreak in China
por: Yang, Qiwen, et al.
Publicado: (2020)

Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
por: Shen, Kuan‐Yin, et al.
Publicado: (2022)

Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
por: Butterfield, Tiffany R., et al.
Publicado: (2021)

Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022
por: Vikse, Elisabeth Lea, et al.
Publicado: (2023)

Duration of anti-SARS-CoV-2 antibodies much shorter in India
por: Kumar, Nishant, et al.
Publicado: (2021)

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
por: Whitcombe, Alana L, et al.
Publicado: (2021)

Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
por: Decaro, Nicola, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in the Republic of Congo in mid-2021
por: Niama, Fabien R., et al.
Publicado: (2022)

Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima – Peru
por: Jara, Luis M., et al.
Publicado: (2021)

Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
por: Kageyama, Takahiro, et al.
Publicado: (2022)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

90 Placental transfer of SARS-CoV-2 specific antibodies from mothers to newborns
por: Estrada Trejo, Fatima A., et al.
Publicado: (2021)

Clinical performance of different SARS‐CoV‐2 IgG antibody tests
por: Kohmer, Niko, et al.
Publicado: (2020)

SARS-CoV-2 Neutralizing Antibodies in White-Tailed Deer from Texas
por: Palermo, Pedro M., et al.
Publicado: (2022)

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
por: Mara, Elisabeth, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race
por: Frediani, Jennifer K., et al.
Publicado: (2023)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
por: Chau, Nguyen Van Vinh, et al.
Publicado: (2021)

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MS
por: de Jong, Karen A.M., et al.
Publicado: (2021)

The prevalence of SARS-CoV-2 antibodies in quarantine workers and high-risk communities in Vietnam
por: Hasan, Tasnim, et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence
por: Gouvea, Maria da Penha Gomes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mj6nj3deufnfvelq4oh0v9dgnf